71.43
-1.91 (-2.60%)
| Previous Close | 73.34 |
| Open | 72.73 |
| Volume | 1,470,453 |
| Avg. Volume (3M) | 1,572,676 |
| Market Cap | 8,635,146,240 |
| Price / Earnings (TTM) | 22.53 |
| Price / Earnings (Forward) | 14.08 |
| Price / Sales | 0.700 |
| Price / Book | 2.56 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | 3.21% |
| Operating Margin (TTM) | 5.75% |
| Diluted EPS (TTM) | 3.21 |
| Quarterly Revenue Growth (YOY) | -0.10% |
| Quarterly Earnings Growth (YOY) | 18.30% |
| Total Debt/Equity (MRQ) | 68.32% |
| Current Ratio (MRQ) | 1.38 |
| Operating Cash Flow (TTM) | 688.00 M |
| Levered Free Cash Flow (TTM) | 548.63 M |
| Return on Assets (TTM) | 4.61% |
| Return on Equity (TTM) | 8.47% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Distribution (US) | Mixed | Mixed |
| Medical Distribution (Global) | Mixed | Bullish | |
| Stock | Henry Schein, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | 0.88 |
|
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. |
|
| Sector | Healthcare |
| Industry | Medical Distribution |
| Investment Style | Small Value |
| % Held by Insiders | 0.84% |
| % Held by Institutions | 107.70% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Palestra Capital Management Llc | 30 Jun 2025 | 3,501,520 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 90.00 (Evercore ISI Group, 26.00%) | Buy |
| Median | 78.00 (9.20%) | |
| Low | 58.00 (Morgan Stanley, -18.80%) | Sell |
| Average | 76.20 (6.68%) | |
| Total | 3 Buy, 1 Hold, 1 Sell | |
| Avg. Price @ Call | 72.01 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barrington Research | 05 Nov 2025 | 79.00 (10.60%) | Buy | 72.01 |
| 22 Oct 2025 | 78.00 (9.20%) | Buy | 63.51 | |
| Evercore ISI Group | 05 Nov 2025 | 90.00 (26.00%) | Buy | 72.01 |
| 26 Aug 2025 | 83.00 (16.20%) | Buy | 69.06 | |
| JP Morgan | 05 Nov 2025 | 78.00 (9.20%) | Buy | 72.01 |
| Morgan Stanley | 05 Nov 2025 | 58.00 (-18.80%) | Sell | 72.01 |
| Wells Fargo | 05 Nov 2025 | 76.00 (6.40%) | Hold | 72.01 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |